Branched-Chain Amino Acids for Maple Syrup Disease Monitoring
HIV-1 Integrase Inhibitor Resistance by Sequencing
Gaucher Disease
Malignant neoplasm, thyroid gland
Survival of Motor Neuron 1 (SMN1) Mutation Analysis
Apolipoprotein A1
Methylmalonic Acid (MMA), Quantitative, Urine
Cytomegalovirus (CMV) DNA by Molecular, Qualitative or Quantitative
Phenytoin, Free, Serum
Platelet Function Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
CPT
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...